Jiancong Sun

437 total citations
12 papers, 340 citations indexed

About

Jiancong Sun is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiancong Sun has authored 12 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jiancong Sun's work include RNA modifications and cancer (3 papers), MicroRNA in disease regulation (3 papers) and Peptidase Inhibition and Analysis (2 papers). Jiancong Sun is often cited by papers focused on RNA modifications and cancer (3 papers), MicroRNA in disease regulation (3 papers) and Peptidase Inhibition and Analysis (2 papers). Jiancong Sun collaborates with scholars based in China, Russia and United States. Jiancong Sun's co-authors include Jian‐Chuan Xia, Wei Yi, Jiongqiang Huang, Zhijie Huang, Jingsong Chen, Ju-Tao Feng, Xiaohui Huang, Yibing Chen, Haiqing Ma and Yongqiang Li and has published in prestigious journals such as International Journal of Cancer, Molecular Cancer and Cancer Letters.

In The Last Decade

Jiancong Sun

11 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiancong Sun China 10 214 160 65 50 41 12 340
Kin‐Fai Cheung Hong Kong 6 267 1.2× 120 0.8× 110 1.7× 34 0.7× 39 1.0× 7 394
Xudong Chen China 12 222 1.0× 203 1.3× 79 1.2× 63 1.3× 21 0.5× 21 348
Sze Keong Tey Hong Kong 12 294 1.4× 217 1.4× 75 1.2× 120 2.4× 40 1.0× 19 447
Guoli Shao China 11 249 1.2× 190 1.2× 73 1.1× 44 0.9× 58 1.4× 18 382
Shrabasti Roychoudhury United States 12 381 1.8× 144 0.9× 87 1.3× 32 0.6× 72 1.8× 17 502
Yinghan Su China 9 204 1.0× 136 0.8× 71 1.1× 28 0.6× 27 0.7× 11 305
Shusen Zheng China 10 342 1.6× 321 2.0× 56 0.9× 25 0.5× 33 0.8× 21 444
Thi Bich Uyen Le Singapore 9 268 1.3× 64 0.4× 63 1.0× 27 0.5× 22 0.5× 11 336

Countries citing papers authored by Jiancong Sun

Since Specialization
Citations

This map shows the geographic impact of Jiancong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiancong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiancong Sun more than expected).

Fields of papers citing papers by Jiancong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiancong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiancong Sun. The network helps show where Jiancong Sun may publish in the future.

Co-authorship network of co-authors of Jiancong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jiancong Sun. A scholar is included among the top collaborators of Jiancong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiancong Sun. Jiancong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Wang, Ge, et al.. (2021). Cyclosporin A impairs neurogenesis and cognitive abilities in brain development via the IFN-γ-Shh-BDNF pathway. International Immunopharmacology. 96. 107744–107744. 12 indexed citations
3.
Huang, Guoliang, Jiancong Sun, Yan Lü, et al.. (2019). MiR-200 family and cancer: From a meta-analysis view. Molecular Aspects of Medicine. 70. 57–71. 54 indexed citations
4.
Sun, Jiancong, et al.. (2018). A Multi-channel System for Qualitative Explosive and Drug Detection. Sensing and Imaging. 19(1). 2 indexed citations
5.
Chen, Jingsong, Jiongqiang Huang, Zhijie Huang, et al.. (2016). MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Cancer Letters. 375(1). 73–83. 88 indexed citations
6.
Liu, Guanglin, Jianfeng Li, Xuan Wei, et al.. (2014). Expression of GOLPH2 is associated with the progression of and poor prognosis in gastric cancer. Oncology Reports. 32(5). 2077–2085. 17 indexed citations
7.
Cheng, Hairong, et al.. (2012). Expression of beclin 1, an autophagy-related protein, in human cervical carcinoma and its clinical significance.. PubMed. 33(1). 15–20. 24 indexed citations
8.
Pan, Ke, MinShan Chen, Jianjun Li, et al.. (2010). Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26(3). 544–549. 22 indexed citations
9.
Ma, Haiqing, Xiaoting Liang, Yibing Chen, et al.. (2010). Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma. International Journal of Cancer. 128(4). 771–777. 34 indexed citations
10.
Ma, Haiqing, Desheng Weng, Yibing Chen, et al.. (2010). Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Molecular Cancer. 9(1). 190–190. 23 indexed citations
11.
Zhang, Yaojun, Qijing Wang, Yongqiang Li, et al.. (2010). Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation. Cancer Biology & Therapy. 9(11). 903–907. 40 indexed citations
12.
Zhang, Huakun, Haiqing Ma, Qijing Wang, et al.. (2010). Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array.. PubMed. 23(2). 445–55. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026